Table 2.
Pathologic nodal status by receipt of neoadjuvant therapy
| Pathologic nodal status | Patients, n (%) |
|---|---|
| Received neoadjuvant therapy | 135 (64.29) |
| ypN0 | 78 (58.0) |
| ypN1 | 13 (9.8) |
| ypN2 | 23 (16.8) |
| ypN3 | 1 (0.7) |
| ypNx/Unknown | 21 (14.7) |
| Did not receive neoadjuvant therapy | 75 (35.71) |
| pN0 | 24 (34.6) |
| pN1 | 6 (7.7) |
| pN2 | 27 (34.6) |
| pN3 | 0 (0) |
| Unknown | 18 (23.1) |
Median survival and 5-year survival are reported for entire resection cohort, by neoadjuvant treatment status, and by lymph node status.